{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:29:45Z","timestamp":1785796185103,"version":"3.56.0"},"reference-count":31,"publisher":"American Chemical Society (ACS)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2016,2,1]]},"DOI":"10.1021\/acs.molpharmaceut.5b00733","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T18:25:12Z","timestamp":1450981512000},"page":"512-519","source":"Crossref","is-referenced-by-count":43,"title":["The Nonmetabolized \u03b2-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3"],"prefix":"10.1021","volume":"13","author":[{"given":"Shingen","family":"Misaka","sequence":"first","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"},{"name":"Department of Pharmacology, School of Medicine, Fukushima Medical University, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Knop","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Singer","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hoier","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Keiser","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Medicine of Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Glaeser","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"K\u00f6nig","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Fromm","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2016,1,19]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9290-9"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1977.tb04609.x"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.241"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.95"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.79"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506483102"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1124\/pr.113.007518"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2013.08.010"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.44"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.014407"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-008-0369-5"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.07.008"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01052.x"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01835-10"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133743"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1515"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12522"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01672.x"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.154518"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-007-0219-x"},{"key":"ref21\/cit21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0026-895X(24)23190-4","volume":"55","author":"Cui Y.","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.67.1.91"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1984.tb04413.x"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M411092200"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(84)90585-4"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1007\/BF00542499"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1021\/mp070028i"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2014.11.002"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1996.tb05904.x"},{"key":"ref30\/cit30","unstructured":"European Medicines Agency. Guideline on the Investigationof Drug Interactions, (2012.http:\/\/www.ema.europa.eu\/ema\/pages\/includes\/document\/open_document.jsp?webContentId=WC500129606."},{"key":"ref31\/cit31","unstructured":"Food and Drug Administration. Guidancefor Industry, DrugInteraction Studies\u2014Study Design, Data Analysis, Implicationsfor Dosing, and Labeling Recommendation, (2012.http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM292362.pdf."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.5b00733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T22:54:58Z","timestamp":1748732098000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.5b00733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,19]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2,1]]}},"alternative-id":["10.1021\/acs.molpharmaceut.5b00733"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00733","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,19]]}}}